ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,875Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 763

$1.89M Total Retail Price of All Prescriptions

Rank: 1 out of 763

678 Patients Receiving at Least One Drug in Part D
20%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 678 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

8% of this provider’s 2,167 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$136 was the average price of a prescription from this provider, compared to $115 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
CITALOPRAM HBR 1,251 251 1 3
RISPERIDONE 1,021 181 2 1
FLUOXETINE HCL 703 71 3 9
TRAZODONE HCL 628 75 4 2
OLANZAPINE 561 136 5 12
BENZTROPINE MESYLATE 554 49 R 6 4
QUETIAPINE FUMARATE 543 47 7 6
ABILIFY 477 21 8 7
BUPROPION HCL SR 471 72 9 15
LAMOTRIGINE 429 53 10 11
BUSPIRONE HCL 420 84 11 19
SERTRALINE HCL 370 74 12 5
VENLAFAXINE HCL ER 359 34 13 8
LITHIUM CARBONATE 308 46 14 17
PAROXETINE HCL 293 107 15 21
DIVALPROEX SODIUM ER 282 52 16 18
ZOLPIDEM TARTRATE 270 46 17 13
MIRTAZAPINE 266 32 18 14
CYMBALTA 258 59 19 16
DIVALPROEX SODIUM 236 33 20 20
ZIPRASIDONE HCL 222 0 21 27
HALOPERIDOL 222 0 21 24
SEROQUEL 205 21 23 26
PERPHENAZINE 201 15 24 31
INVEGA SUSTENNA 171 12 25 36
ESCITALOPRAM OXALATE 152 21 26 23
DOXEPIN HCL 139 51 27 34
CLOMIPRAMINE HCL 135 15 R 28 56
METHYLPHENIDATE HCL 134 11 29 43
BUPROPION XL 127 23 30 25
SEROQUEL XR 122 27 31 28
CLOZAPINE 113 0 32 10
DONEPEZIL HCL 113 47 32 35
AMPHETAMINE SALT COMBO 108 0 S2 34 33
HYDROXYZINE PAMOATE 92 0 R 35 29
THIOTHIXENE 92 23 35 57
ZYPREXA 91 36 37 68
FLUVOXAMINE MALEATE 91 13 37 42
CHLORPROMAZINE HCL 90 40 39 37
GABAPENTIN 81 0 40 22
AMITRIPTYLINE HCL 72 13 R 41 41
GEODON 71 0 42 52
ZYPREXA RELPREVV 70 0 43 118
LEXAPRO 66 24 44 54
NORTRIPTYLINE HCL 65 23 45 55
CARBAMAZEPINE 64 13 46 32
IMIPRAMINE HCL 60 16 R 47 89
THIORIDAZINE HCL 56 44 R 48 67
INVEGA 56 0 48 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.